Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis

Journal of Surgical Oncology

Volumn 106, Issue 2, 2012, Pages 169-173

  Xu, Lai ^a   Wang, Wei Bin ^a   Zhao, Yu Pei ^a   Zhang, Tai Ping ^a   Liao, Quan ^a   Chen, Ge ^a   Zhou, Li ^a   Shu, Hong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

medullary thyroid carcinoma; nodular goiter; survival

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN;

ADOLESCENT; ADULT; AGED; CALCITONIN BLOOD LEVEL; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; REVIEW; SUBTOTAL THYROIDECTOMY; SURVIVAL PREDICTION; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; CHINA; FEMALE; GOITER, NODULAR; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NERVOUS SYSTEM NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SAMPLE SIZE; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL; VASCULAR NEOPLASMS;

EID: 84863715621     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23070     Document Type: Review

References (29)

1. Hazard JB, Hawk WA, Crile G, Jr.:, Medullary (solid) carcinoma of the thyroid: A clinicopathologic entity. J Clin Endocrinol Metab 1959; 19: 152-161.
2. Kebebew E, Ituarte PH, Siperstein AE, et al.: Medullary thyroid carcinoma: Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000; 88: 1139-1148. (Pubitemid 30127676)
3. Gilliland FD, Hunt WC, Morris DM, et al.: Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program, 1973-1991. Cancer 1997; 79: 564-573. (Pubitemid 27051783)
4. Hundahl SA, Fleming ID, Fremgen AM, et al.: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998; 83: 2638-2648. (Pubitemid 29019586)
5. Hanna FWF, Ardill JES, Johnston CF, et al.: Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. J Endocrinol 1997; 152: 275-281. (Pubitemid 27115777)
6. Meijer JA, le Cessie S, van den Hout WB, et al.: Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: A structured meta-analysis. Clin Endocrnol (Oxf) 2010; 72: 534-542.
7. Brandi ML, Gagel RF, Angeli A, et al.: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86: 5658-5671. (Pubitemid 33152604)
8. Deepak T, Abraham MS, Low T-H, et al.: Medullary thyroid carcinoma: Long-term outcomes of surgical treatment. Ann Surg Oncol 2011; 18: 219-225.
9. Mulligan LM, Kwok JB, Healey CS, et al.: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460. (Pubitemid 23179393)
10. Treseler PA, Clark OH:, Prognostic factors in thyroid carcinoma. Surg Oncol Clin N Am 1997; 6: 555-598. (Pubitemid 27318304)
11. Miccoli P, Minuto MN, Ugolini C, et al.: Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer. Endocr Relat Cancer 2007; 14: 1099-1105. (Pubitemid 351252441)
12. Grozinsky-Glasberg S, Benbassat CA, Tsvetov G, et al.: Medullary thyroid cancer: A retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. Thyroid 2007; 17: 549-556. (Pubitemid 47068118)
13. Pellegriti G, Leboulleux S, Baudin E, et al.: Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. Br J Cancer 2003; 88: 1537-1542. (Pubitemid 36713778)
14. Kandil E, Gilson MM, Alabbas HH, et al.: Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer. Ann Surg Oncol 2011; 18: 1028-1034.
15. Hyer SL, Vini L, A'Hern R, et al.: Medullary thyroid cancer: Multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol 2000; 26: 686-690.
16. Ito Y, Miyauchi A, Yabuta T, et al.: Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: Experience of a single institution. World J Surg 2009; 33: 58-66.
17. Roman S, Lin R, Sosa JA:, Prognosis of medullary thyroid carcinoma: Demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 2006; 107: 2134-2142. (Pubitemid 44665646)
18. Hedinger C, Williams ED, Sobin LH:, The WHO histological classification of thyroid tumors: A commentary on the second edition. Cancer 1989; 63: 908-911. (Pubitemid 19063200)
19. Paschke R:, Molecular pathogenesis of nodular goiter. Langenbecks Arch Surg 2011; 396: 1127-1136.
20. Sobin LH, Wittekind CH, editors. UICC: TNM classification of malignant tumors, 6th edition. New York: Wiley-Liss; 2002.
21. Namba h, Matsuo K, Fagin JA:, Clonal composition of benign and malignant human thyroid tumors. J Clin Invest 1990; 86: 120-125. (Pubitemid 20226983)
22. Nishimura A, Shirai Y, Hatakeyama K, et al.: Toxic nodular goiter with thyroid papillary microcarcinoma. Surgery 1999; 126: 587-588.
23. Iqbal M, Mehmood Z, Rasul S, et al.: Carcinoma thyroid in multi and uninodular goiter. J Coll Physicians Surg Pak 2010; 20: 10-12.
24. Edino ST, Mohammed AZ, Ochicha O, et al.: Thyroid cancers in nodular goiter in Kano, Nigeria. Niger J Clin Pract 2010; 13: 298-300.
25. Krohn K, Fuhrer D, Bayer Y, et al.: Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 2005; 26: 504-524. (Pubitemid 41014264)
26. Bayer Y, Neumann S, Meyer B, et al.: Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J Clin Endocrinol Metab 2004; 89: 4044-4052. (Pubitemid 39071512)
27. van Heerden JA, Grant CS, Gharib H, et al.: Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990; 212: 395-400.
28. Saad MF, Fritsche HA, Jr., Samaan NA:, Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. J Clin Endocrinol Metab 1984; 58: 889-894. (Pubitemid 14102114)
29. Barbet J, Campion L, Kraeber-Bodere F, et al.: Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2005; 90: 6077-6084. (Pubitemid 41606528)